🇺🇸 FDA
Pipeline program

IMC-I109V Single Ascending Dose

IMC-I109V-101

Phase 1 small_molecule terminated

Quick answer

IMC-I109V Single Ascending Dose for Hepatitis B, Chronic is a Phase 1 program (small_molecule) at Immunocore Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Immunocore Ireland Limited
Indication
Hepatitis B, Chronic
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials